FDA notifications.  New labeling for Videx pediatric powder.
D002648:Child; D000075202:Contraindications; D016049:Didanosine / Q000008:administration & dosage / Q000009:adverse effects; D004347:Drug Interactions; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D006801:Humans; D010372:Pediatrics; D011208:Powders; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D011208:Powders; D018894:Reverse Transcriptase Inhibitors; D016049:Didanosine